Streetbeat News

Revenues

SNA

Snap-on (NYSE:SNA) has received diverse analyst ratings in the last three months, with a recent shift towards a somewhat bearish stance. The average 12-month price target for SNA has been raised to $315.25, indicating a 31.35% increase from the previous target. Analysts from B of A Securities, Tigress Financial, and Barrington Research have updated their ratings and price targets, reflecting their current views on the company's performance and market position. Snap-on's financial indicators such as market capitalization, revenue growth, net margin, ROE, ROA, and debt management are also discussed, providing a comprehensive overview of its financial health and market standing.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 12:00 pm

CHGG

Recent analyst ratings for Chegg (NYSE:CHGG) show a mix of neutral and bearish perspectives, with no bullish ratings. The average 12-month price target is now $8.5, down from $9.67, indicating a negative sentiment shift. Analysts from firms like JP Morgan, BMO Capital, Piper Sandler, and Goldman Sachs have adjusted their price targets and ratings, reflecting concerns over Chegg's market performance, revenue decline, and financial management challenges.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 12:00 pm

ASGN

ASGN announced that its brand ECS has been named as the prime contractor on a $500 million ARPA-H IDIQ contract, positioning the company for significant involvement in future health projects.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:31 am

USPH

U.S. Physical Therapy announced a change in the Medicare rate reduction for the remainder of 2024. The new rate reduction effective March 9, 2024, will be approximately 1.8%, a decrease from the previously expected 3.5%. This change is not retroactive to January 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:24 am

BEKE

BIDU

BILI

JD

PDD

Chinese stocks are trading higher after the National People's Congress event and a rise in China's consumer price index, which may alleviate deflation concerns.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 10:55 am

ENSV

Enservco reported a 15% increase in revenue for the first two months of 2024 compared to the previous year. Additionally, the company announced the dismissal of a class action lawsuit by the U.S. District Court for the District of Colorado.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 10:47 am

FTRE

Fortrea has projected its 2024 sales to be in the range of $3.14B-$3.205B, slightly below the consensus estimate of $3.20B. The company also forecasts its adjusted EBITDA to be between $280M-$320M.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 10:38 am

SPY

Despite improvements in Americans' assessment of the economy and their personal financial situations, President Joe Biden's approval rating on economic management remains unchanged at 36%. A new poll indicates that 40% of respondents trust former President Trump over Biden (34%) for better economic handling. The U.S. economy has shown growth with a 3.2% GDP increase in 2023 and a robust job market, yet inflation remains a concern. The SPDR S&P 500 ETF Trust (SPY) reached a record high, reflecting economic optimism.

Portfolio Pulse from Shanthi Rexaline

March 11, 2024 | 9:46 am

MDT

Medtronic shared new clinical and real-world evidence on Saturday about the MiniMed 780G system from early users in the United States, indicating that the system sustains strong global performance and exceeds international targets for diabetes management.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:40 am

ASX

ASE Technology reported its February 2024 consolidated net revenues of $1.269 billion. This financial update is crucial for investors monitoring the company's performance.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:37 am